PharmaBoardroom

With advances in technology, an increasing number of stable peptide-based therapeutics are being brought to market today across a wide range of…

While supporters of Turkey’s localization policy for pharmaceuticals implemented in 2016 applaud the changes it has brought, its opponents are…

Zealand Pharma’s Emmanuel Dulac, fresh from a first US FDA approval for the company’s rescue pen for severe hypoglycaemia in people with diabetes…

Speaking recently to PharmaBoardoom, Assobiotec’s Leonardo Vingiani introduced the key dynamics shaping the Italian biotech industry today and the…

The latest news from German pharma, including Bayer’s USD 2 billion acquisition of San Diego’s Vividion Therapeutics; Boehringer Ingelheim’s new…

Assobiotec's Leonardo Vingiani introduces the key trends shaping the Italian biotech ecosystem today, the steps that the country's government have…

The Lymphoma Coalition’s Natacha Bolaños outlines the fundamentals of the lymphoma patient experience today, the growing number of innovative new…

This piece forms part of InFocus Biotechs to Watch Switzerland 2021, a deep dive into the Swiss biotech ecosystem and fundamentals, featuring data…

Since joining Danish neuroscience specialist Lundbeck as its global CEO in 2018, South African Deborah Dunsire has focused on “revitalising and…

Speaking exclusively to PharmaBoardroom, Lundbeck’s global CEO Deborah Dunsire describes the progress in the strategy she put in place to…

The Top Five countries in Europe for pharma production. All located in Western Europe, Switzerland punches well above its weight to take top spot.…

The global push to vaccinate populations against COVID-19 has played out differently in different geographies, with a yawning gap still existing…